(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SIGHTNOVO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

SIGHTNOVO

ST13

US500000079305511

Class

5, 10, 44

Filing

79305511

Registration

6696092

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

24

Latest update

09/26/2022

Trademark type

Combined

Nice classes

5, 10, 44

Filing date

12/29/2020

Registration date

04/12/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/12/2022

Last transaction

04/12/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

03

Owner location

CN

Examiner

MESSICK, TABITHA

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized wording "SIGHTNOVO" with the first "O" letter shaded with a transparent star in the middle and a curved line above and below the letter.

Holders and representatives

Holders

Hangzhou Sightnovo Medical Technology Co.,Ltd.

Representatives

Nazly Aileen Bayramoglu Bayramoglu Law Offices LLC

Technical classification

Nice Classes

Class 5Class 10Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Chemico-pharmaceutical preparations for use in the diagnosis and accurate treatment of ophthalmic diseases; diagnostic biomarker reagents for medical purposes; dietetic substances in the nature of beverages adapted for medical use; dietetic foods adapted for medical purposes; diagnostic preparations for medical purposes; reagent paper for medical purposes; pre-filled syringes for medical purposes with triamcinolone acetonide suspension and dexamethasone suspension; pharmaceutical preparations for use in the diagnosis and accurate treatment of ophthalmic diseases; nutraceutical preparations for therapeutic or medical purposes for treatment of ophthalmic diseases; nutritional supplements

Class 10

Medical apparatus and instruments for diagnosingtreatingpreventing ophthalmic diseases; cases fitted for medical instruments; syringes for injections; hypodermic syringes; syringes for medical purposes; injectors for medical purposesmedical fluid injectors; medical diagnostic apparatus for testing for viruses; medical diagnostic apparatus for analyzing electrolytes in the body; Medical diagnostic apparatus for detecting cancer; needles for medical purposes

Class 44

Hospital services; services of a psychologist; nutritional therapy servicesmental health therapy services; telemedicine services; health counselling; health care; nursingmedical; medical equipment rental; medical clinic services

Publications

History of USPTO decisions and trademark events.

24 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

09/26/2022

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

08/26/2022

XXCR

GENERIC MADRID TRANSACTION CREATED

08/26/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/12/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

04/12/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/25/2022

PUBO

PUBLISHED FOR OPPOSITION

01/25/2022

GPNX

NOTIFICATION PROCESSED BY IB

01/22/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/05/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

01/05/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/05/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/18/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/14/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/13/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/13/2021

RFNT

REFUSAL PROCESSED BY IB

08/08/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

07/20/2021

RFRR

REFUSAL PROCESSED BY MPU

07/20/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

07/03/2021

CNRT

NON-FINAL ACTION WRITTEN

07/02/2021

DOCK

ASSIGNED TO EXAMINER

06/29/2021

MAFR

APPLICATION FILING RECEIPT MAILED

03/09/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/05/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/04/2021

Continuous trademark protection

Get notified about every new filing that threatens SIGHTNOVO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.